Pregnancy and Crohn's disease: Infliximab induction therapy, accidental conception, pregnancy outcome and postpartum complications

Annals of Gastroenterology

Volumn 19, Issue 2, 2006, Pages 138-140

  Xirouchakis, Elmo ^a   Karantanos, P ^a   Tsartsali, Lemonia ^b   Karkatzos, E ^a  

^a 1st IKA Hospital   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Inflammatory bowel disease; Infliximab; Pregnancy

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INFLIXIMAB; MESALAZINE; PREDNISOLONE; PREDNISONE;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; ACUTE ABDOMEN; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONCEPTION; CROHN DISEASE; CYST RUPTURE; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FEVER; HUMAN; OVARY CYST; PREGNANCY OUTCOME; PROTEIN BLOOD LEVEL; PUERPERIUM; REMISSION; VAGINA BLEEDING;

EID: 34548534530     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Donaldson LB. Crohn's disease: Its gynecologic aspect. Am J Obstet Gynecol. 1978; 131:196-202.
2. Katz JA, Keenan GF, Snith DE, et al. Outcome of Pregnancy in patients receiving infliximab for the treatment of crohn's disease and rheumatoid arthritis Gastroenterology 2003; 124 (4, Suppl.1):Abstr.No63.
3. Weber AM, Ziegler C, Belinson JL, et al. Gynecologic history in women with inflammatory bowel disease. Obstet Gynecol 1995; 86:843-847.
4. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986; 27:821-825.
5. Kornfeld D, Cnattinguis S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease. A population based cohort study. Am J Obstet Gynecol 1997; 177:942-946.
6. Subhani JM, Hamilton MI. Review article: the management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 1998; 12:1039-1053.
7. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998; 27:213-224.
8. Connell W, Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of therapy. Drug Safety 1999; 21:311-323.
9. Larzilliere I, Beau P. Chronic inflammatory bowel disease and pregnancy-case control study. Gastroenterol Clin Biol 1998; 22:1056-1060.
10. Fonager K, Sorensen HT, Olsen J et al. Pregnancy outcome for women with Crohn's disease. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93:2426-2430.
11. Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 1995; 38:1722-1732.
12. Jospe ES, Pepercorn MA. Inflammatory bowel disease and pregnancy: a review. Dig Dis 1999; 17:201-207.
13. Cappell MS, Sidhom O, Colon V. A study at ten medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 1996; 41:2353-2360.
14. Katz JA, Lichtenstein GR, Keenan GF, et al. Outcome of pregnancy in woman receiving remicade (infliximab) for the treatment of Crohn's Disease and Rheumatoid Arthritis. Gastroenterology 2001; 120(5, Supp.1):A-69
15. Baioco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clinical Gastroenterol 1984; 6:211-216.
16. Tarjan Z, Toth G, et al. Ultrasound in Crohn's disease of the small bowel. Eur Journal of Radiology 2000; 35:176-182.